摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ditert-butyl-[2-[(4S)-4-tert-butyl-4,5-dihydro-1,3-oxazol-2-yl]-2-methylpropyl]phosphane | 1232140-70-3

中文名称
——
中文别名
——
英文名称
ditert-butyl-[2-[(4S)-4-tert-butyl-4,5-dihydro-1,3-oxazol-2-yl]-2-methylpropyl]phosphane
英文别名
——
ditert-butyl-[2-[(4S)-4-tert-butyl-4,5-dihydro-1,3-oxazol-2-yl]-2-methylpropyl]phosphane化学式
CAS
1232140-70-3
化学式
C19H38NOP
mdl
——
分子量
327.491
InChiKey
YONKTUNOTFYZCR-CQSZACIVSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.1
  • 重原子数:
    22
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.95
  • 拓扑面积:
    21.6
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    (S)-4-tert-butyl-2-(1-chloro-2-methylpropan-2-yl)-4,5-dihydrooxazole二-叔丁基膦正丁基锂 作用下, 以 四氢呋喃正己烷 为溶剂, 以60%的产率得到ditert-butyl-[2-[(4S)-4-tert-butyl-4,5-dihydro-1,3-oxazol-2-yl]-2-methylpropyl]phosphane
    参考文献:
    名称:
    Chiral ligands
    摘要:
    化学式(1)的手性化合物,其光学纯度高或光学富集,其中R0是未取代或取代1至2个C1-C4-烷氧基的C1-C12-烷基;环戊基或环己基,未取代或取代1至3个C1-C4-烷基或C1-C4-烷氧基;或苄基,苯基或萘基,未取代或取代1至3个C1-C4-烷基,C1-C4-烷氧基,C1-C4-氟烷基或C1-C4-氟烷氧基,F或Cl,R1和R'1中的每一个独立地是氢或具有R0的含义,其中R1,R'1和R0可以相同也可以不同,R2和R3独立地是C键合的碳氢基团或杂原子碳氢基团,R4中的每一个都是C1-C6-烷基,环戊基,环己基,苯基,甲基苯基,甲基苄基或苄基,或者两个R4一起形成一个脂肪族C4-C6碳环。这些配体的金属络合物是对不对称加成反应,尤其是氢化反应的均相催化剂。
    公开号:
    EP2202236A1
点击查看最新优质反应信息

文献信息

  • CHIRAL LIGANDS
    申请人:Pfaltz Andreas
    公开号:US20110275826A1
    公开(公告)日:2011-11-10
    Chiral compounds of the formula (1), which are optically pure or highly optically enriched in which R 0 is C 1 -C 12 -alkyl which is unsubstituted or substituted by 1 to 2 C 1 -C 4 -alkoxy; cyclo-pentyl or cyclohexyl, which is unsubstituted or substituted by 1 to 3 C 1 -C 4 -alkyl or C 1 -C 4 -alkoxy; or benzyl, phenyl or naphtyl which is unsubstituted or substituted by 1 to 3 C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -fluoroalkyl or C 1 -C 4 -fluoroalkoxy, F or Cl, or R 0 is —CR 5 R 6 OH or —CR 5 R 6 OSi(C 1 -C 8 -alkyl) 3 wherein R 5 and R 6 are independently selected from the group consisting of H, unsubstituted C 1 -C 12 alkyl, substituted C 1 -C 12 alkyl, unsubstituted C 4 -C 8 cyclo alkyl, substituted C 4 -C 8 cyclo alkyl, unsubstituted aryl, substituted aryl or wherein R 5 and R 6 can form an unsubstituted 5-6 membered aliphatic carbocycle or a substituted 5-6 membered aliphatic carbocycle, each of R 1 and R′ 1 independently is hydrogen or has the meaning of R 0 whereby R 1 , R′ 1 and R 0 can be same or different, R 2 and R 3 are independently a C-bonded hydrocarbon radical or a heterohydrocarbon radical, and each of both R 4 is C 1 -C 6 -alkyl, cyclopentyl, cyclohexyl, phenyl, methylphenyl, methylbenzyl or benzyl, or both R 4 together form an aliphatic C 4 -C 6 carbocycle. Metal complexes of these ligands are homogeneous catalysts for asymmetric addition reaction, particularly hydrogenations.
  • [EN] CHIRAL LIGANDS<br/>[FR] LIGANDS CHIRAUX
    申请人:SOLVIAS AG
    公开号:WO2010072746A1
    公开(公告)日:2010-07-01
    Chiral compounds of the formula (1 ), which are optically pure or highly optically enriched in which R0 is C1-C12-alkyl which is unsubstituted or substituted by 1 to 2 C1-C4-alkoxy; cyclo- pentyl or cyclohexyl, which is unsubstituted or substituted by 1 to 3 C1-C4-alkyl or C1-C4-alkoxy; or benzyl, phenyl or naphtyl which is unsubstituted or substituted by 1 to 3 C1-C4-alkyl, C1-C4-alkoxy, C1-C4-fluoroalkyl or C1-C4-fluoroalkoxy, F or Cl, or R0 is -C R5 R6 OH or -C R5 R6 OSi(C1-C8-alkyl)3 wherein R5 and R6 are indedendently selected from the group consisting of H, unsubstituted C1 - C12 alkyl, substituted C1 - C12 alkyl, unsubstituted C4 - C8 cyclo alkyl, substituted C4 - C8 cyclo alkyl, unsubstituted aryl, substituted aryl or wherein R5 and R6 can form an unsubstituted 5-6 membered aliphatic carbocycle or a substituted 5-6 membered aliphatic carbocycle, each of R1 and R'1 independently is hydrogen or has the meaning of R0 whereby R1, R'1 and R0 can be same or different, R2 and R3 are independently a C-bonded hydrocarbon radical or a heterohydrocarbon radical, and each of both R4 is C1-C6-alkyl, cyclopentyl, cyclohexyl, phenyl, methylphenyl, methylbenzyl or benzyl, or both R4 together form an aliphatic C4-C6 carbocycle. Metal complexes of these ligands are homogeneous catalysts for asymmetric addition reaction, particularly hydrogenations.
  • Chiral ligands
    申请人:Solvias AG
    公开号:EP2202236A1
    公开(公告)日:2010-06-30
    Chiral compounds of the formula (1), which are optically pure or highly optically enriched in which R0 is C1-C12-alkyl which is unsubstituted or substituted by 1 to 2 C1-C4-alkoxy; cyclopentyl or cyclohexyl, which is unsubstituted or substituted by 1 to 3 C1-C4-alkyl or C1-C4-alkoxy; or benzyl, phenyl or naphtyl which is unsubstituted or substituted by 1 to 3 C1-C4-alkyl, C1-C4-alkoxy, C1-C4-fluoroalkyl or C1-C4-fluoroalkoxy, F or Cl, each of R1 and R'1 independently is hydrogen or has the meaning of R0 whereby R1, R'1 and R0 can be same or different, R2 and R3 are independently a C-bonded hydrocarbon radical or a heterohydrocarbon radical, and each of both R4 is C1-C6-alkyl, cyclopentyl, cyclohexyl, phenyl, methylphenyl, methylbenzyl or benzyl, or both R4 together form an aliphatic C4-C6 carbocycle. Metal complexes of these ligands are homogeneous catalysts for asymmetric addition reaction, particularly hydrogenations.
    化学式(1)的手性化合物,其光学纯度高或光学富集,其中R0是未取代或取代1至2个C1-C4-烷氧基的C1-C12-烷基;环戊基或环己基,未取代或取代1至3个C1-C4-烷基或C1-C4-烷氧基;或苄基,苯基或萘基,未取代或取代1至3个C1-C4-烷基,C1-C4-烷氧基,C1-C4-氟烷基或C1-C4-氟烷氧基,F或Cl,R1和R'1中的每一个独立地是氢或具有R0的含义,其中R1,R'1和R0可以相同也可以不同,R2和R3独立地是C键合的碳氢基团或杂原子碳氢基团,R4中的每一个都是C1-C6-烷基,环戊基,环己基,苯基,甲基苯基,甲基苄基或苄基,或者两个R4一起形成一个脂肪族C4-C6碳环。这些配体的金属络合物是对不对称加成反应,尤其是氢化反应的均相催化剂。
查看更多

同类化合物

(4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] 香豆素-6-羧酸 锌离子载体IV 钐(III) 离子载体 II 苯,(2,2-二氟乙烯基)- 聚二硫二噻唑烷 缩胆囊肽9 甲酰乙内脲 甲巯咪唑 甲基羟甲基油基噁唑啉 甲基5-羟基-3,5-二甲基-4,5-二氢-1H-吡唑-1-羧酸酯 甲基5-甲基-4,5-二氢-1H-吡唑-1-羧酸酯 甲基5-氰基-4,5-二氢-1,2-恶唑-3-羧酸酯 甲基5-乙炔基-4,5-二氢-1H-吡唑-3-羧酸酯 甲基4-甲基-5-氧代-4,5-二氢-1H-吡唑-3-羧酸酯 甲基4-甲基-4,5-二氢-1H-吡唑-3-羧酸酯 甲基4-乙炔基-4,5-二氢-1H-吡唑-3-羧酸酯 甲基4,5-二氮杂螺[2.4]庚-5-烯-6-羧酸酯 甲基4,5-二氢-5-乙基-1H-吡唑-1-羧酸酯 甲基(E)-3-[6-[1-羟基-1-(4-甲基苯基)-3-(1-吡咯烷基)丙基]-2-吡啶基]丙烯酰酸酯 甲基(5-氧代-4,5-二氢-1,2-恶唑-3-基)乙酸酯 环戊二烯并[d]咪唑-2,5(1H,3H)-二硫酮 溶剂黄93 溴化1-十六烷基-3-甲基咪唑 溴化1-十二烷基-2,3-二甲基咪唑 泰比培南酯中间体 泰比培南酯中间体 氨基甲硫酸,[2-[[(2-羰基-1-咪唑烷基)硫代甲基]氨基]乙基]-,O-甲基酯 异噻唑,4,5-二氯-2,5-二氢-2-辛基- 希诺米啉 四氟硼酸二氢1,3-二(叔-丁基)-4,5--1H-咪唑正离子 四唑硝基紫 噻唑丁炎酮 噻唑,4,5-二氢-4-(1-甲基乙基)-,(S)- 噁唑,4,5-二氢-4,4-二甲基-2-(5-甲基-2-呋喃基)- 噁唑,2-庚基-4,5-二氢- 咪唑烷基脲 吡嗪,2,3-二氢-5,6-二甲基-2-丙基- 叔-丁基3-羟基-1,4,6,7-四氢吡唑并[4,3-c]吡啶-5-羧酸酯 双吡唑啉酮 双[(S)-4-异丙基-4,5-二氢噁唑-2-基]甲烷 双((R)-4-(叔丁基)-4,5-二氢恶唑-2-基)甲烷 利美尼啶D4 利美尼啶 假硫代乙内酰脲 依达拉奉杂质DO 依达拉奉杂质 依达拉奉三聚体 依达拉奉 仲班酸